FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080638 [Registered on: 17/02/2025] Trial Registered Prospectively
Last Modified On: 01/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Effect of 3% Saline on optic nerve sheath size and its correlation with blood flow in the brain in patients with moderate to severe head injury 
Scientific Title of Study   3% Hypertonic saline induced changes in Optic Nerve Sheath Diameter (ONSD) and its correlation with Transcranial colour coded Duplex (TCCD) parameters in patients with moderate to severe Traumatic Brain Injury (TBI): A prospective observational study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pharanitharan  
Designation  Senior resident (Academic) 
Affiliation  All India institute of medical sciences Jodhpur  
Address  Department of Anaesthesiology and Critical care,AICU(3rd floor),AIIMS Jodhpur ,Basni,industrial area phase 2 Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  8012820356  
Fax    
Email  pharanitharan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sadik Mohammed 
Designation  Additional professor 
Affiliation  All India institute of medical sciences Jodhpur  
Address  Department of Anaesthesiology and Critical care,AICU(3rd floor),AIIMS Jodhpur, Basni,industrial area phase 2,Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  9414849733  
Fax    
Email  drmsadik@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pharanitharan  
Designation  Senior resident (Academic) 
Affiliation  All India institute of medical sciences Jodhpur  
Address  Department of Anaesthesiology and Critical care,AICU(3rd floor) ,AIIMS Jodhpur,Basni,industrial area phase 2,Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  8012820356  
Fax    
Email  pharanitharan@gmail.com  
 
Source of Monetary or Material Support  
All India institute of medical sciences(AIIMSJodhpur),Basni industrial Area Phase-2,Jodhpur,Rajasthan,India. PIN code-342005 
 
Primary Sponsor  
Name  All India institute of medical sciences Jodhpur  
Address  Department of Anaesthesiology and Critical care ,AICU(3rd floor), AIIMS Jodhpur ,Basni ,industrial area phase 2,Jodhpur  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sadik Mohammed  All India institute of medical sciences Jodhpur   Department of Anaesthesiology & Critical care,AICU(3rd floor),AIIMS Jodhpur,Basni,industrial area phase 2,Jodhpur
Jodhpur
RAJASTHAN 
9414849733

drmsadik@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,AIIMS Jodhpur   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S062||Diffuse traumatic brain injury,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1.Adult patient aged 18yrs and above
2.admitted in ICU
3.Diagnosed with Moderate/severe TBI requiring hypertonic saline therapy  
 
ExclusionCriteria 
Details  1.patient refusal
2.preexisting optic nerve disorders
3.spontaneous intracranial haemorrhage,stroke
4.skull fractures
5.hemodynamic instability
6.brain stem death  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the correlation between change in ONSD and change in TCCD parameters following 3% hypertonic saline therapy in patients with moderate to severe traumatic brain injury TBI.  Baseline,10mins and 1hr after hypertonic saline administration from ICU admission till day 5 of ICU or continuation of hypertonic saline therapy whichever is earlier  
 
Secondary Outcome  
Outcome  TimePoints 
1.To assess the correlation between changes in TCCD parameters and clinical improvement [change in Glasgow Coma Scale (GCS)] in patients with moderate to severe TBI following 3% hypertonic saline therapy.
2.To assess the correlation between changes in ONSD and clinical improvement (change in GCS) in patients with moderate to severe TBI following 3% hypertonic saline therapy.
3.To assess the effects of 3% hypertonic saline administration on electrolyte disturbances and hemodynamic parameters in patients with TBI.
4.To evaluate clinical outcomes including length of ICU stay, length of ventilatory stay, incidence of AKI, total hospital length of stay, and mortality rates 
1.GCS,serum electrolytes and hemodynamic parameters during ICU admission and till day 5 of ICU.
2.clinical outcomes will be noted till hospital stay or till the date of death in hospital  
 
Target Sample Size   Total Sample Size="85"
Sample Size from India="85" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

After CTRI approval, our study will enroll patients with moderate to severe traumatic brain injury to observe the 3% hypertonic saline-induced changes in optic nerve sheath diameter (ONSD) and transcranial color-coded Doppler (TCCD) parameters and assess the correlation between them.


The primary objective is to establish a correlation between changes in ONSD and TCCD parameters following hypertonic saline therapy. Secondary objective is to assess the correlation between clinical improvement (change in GCS) with changes in TCCD parameters and ONSD in patients with moderate to severe TBI following hypertonic saline. To assess the effects of 3% hypertonic saline administration on electrolyte disturbances and hemodynamic parameters in patients with TBI. To evaluate clinical outcomes including length of ICU stay, length of ventilatory stay, incidence of AKI, total hospital length of stay, and mortality rates.


Data will be collected at baseline (before therapy) at the time of ICU admission, 10 minutes post-therapy, 1 hour post-therapy, and daily for 5 days or until the administration of hypertonic saline therapy, whichever is earlier. Clinical outcomes will be noted until hospital discharge or the date of death in the hospital.

 
Close